Patient powered research: an approach to building capacity for a hardly reached patient population to engage in cancer research.

Black patients Cancer research Patient advisory council Patient engagement Patients of color

Journal

Research involvement and engagement
ISSN: 2056-7529
Titre abrégé: Res Involv Engagem
Pays: England
ID NLM: 101708164

Informations de publication

Date de publication:
26 Oct 2021
Historique:
received: 01 07 2021
accepted: 15 10 2021
entrez: 27 10 2021
pubmed: 28 10 2021
medline: 28 10 2021
Statut: epublish

Résumé

Participating in clinical trials is a metric of high-quality cancer care and improves survival. However, Black individuals with cancer are less likely to be enrolled in clinical trials and experience a disproportionate burden of cancer mortality compared to Whites. Patient-engaged research is one potential strategy to address racial inequities in clinical trials, but little is known about best practices for engaging Black individuals and communities impacted by cancer in research partnerships. We used a community engaged research approach to establish a patient advisory council (PAC) representative of the patient population served by a safety net hospital cancer center. We outline the process of establishing the PAC and the lessons learned. The inaugural PAC included 7 members representative of the cancer center's patient demographics. PAC members developed a patient centered vision, mission and action plan. PAC and community-academic research partners experienced the transformative power of centering the lived experiences of patients of color to promote health equity in cancer research. Establishing a patient advisory council at a safety net hospital cancer care center provided a platform for engaging a hardly reached population in patient centered research. Participating in clinical trials is an important measure of high-quality cancer care and improves survival. However, Black individuals with cancer are less likely to participate in clinical trials and are more likely to die from cancer compared to Whites. Including Black patients as research partners is one way to improve racial equity in clinical trial participation. We established a patient advisory council (PAC) including patients and caregivers with similar racial demographics as the patients receiving care at a safety net hospital cancer center. PAC members partnered with the research team to develop a vision, mission, and action plan to improve research participation among patients of color. PAC members used their lived experiences and training from the research team to help develop a strategy to improve representation of patients of color in cancer research. This paper is focused on the PAC development process.

Sections du résumé

BACKGROUND BACKGROUND
Participating in clinical trials is a metric of high-quality cancer care and improves survival. However, Black individuals with cancer are less likely to be enrolled in clinical trials and experience a disproportionate burden of cancer mortality compared to Whites. Patient-engaged research is one potential strategy to address racial inequities in clinical trials, but little is known about best practices for engaging Black individuals and communities impacted by cancer in research partnerships.
METHODS METHODS
We used a community engaged research approach to establish a patient advisory council (PAC) representative of the patient population served by a safety net hospital cancer center. We outline the process of establishing the PAC and the lessons learned.
RESULTS RESULTS
The inaugural PAC included 7 members representative of the cancer center's patient demographics. PAC members developed a patient centered vision, mission and action plan. PAC and community-academic research partners experienced the transformative power of centering the lived experiences of patients of color to promote health equity in cancer research.
CONCLUSION CONCLUSIONS
Establishing a patient advisory council at a safety net hospital cancer care center provided a platform for engaging a hardly reached population in patient centered research.
Participating in clinical trials is an important measure of high-quality cancer care and improves survival. However, Black individuals with cancer are less likely to participate in clinical trials and are more likely to die from cancer compared to Whites. Including Black patients as research partners is one way to improve racial equity in clinical trial participation. We established a patient advisory council (PAC) including patients and caregivers with similar racial demographics as the patients receiving care at a safety net hospital cancer center. PAC members partnered with the research team to develop a vision, mission, and action plan to improve research participation among patients of color. PAC members used their lived experiences and training from the research team to help develop a strategy to improve representation of patients of color in cancer research. This paper is focused on the PAC development process.

Autres résumés

Type: plain-language-summary (eng)
Participating in clinical trials is an important measure of high-quality cancer care and improves survival. However, Black individuals with cancer are less likely to participate in clinical trials and are more likely to die from cancer compared to Whites. Including Black patients as research partners is one way to improve racial equity in clinical trial participation. We established a patient advisory council (PAC) including patients and caregivers with similar racial demographics as the patients receiving care at a safety net hospital cancer center. PAC members partnered with the research team to develop a vision, mission, and action plan to improve research participation among patients of color. PAC members used their lived experiences and training from the research team to help develop a strategy to improve representation of patients of color in cancer research. This paper is focused on the PAC development process.

Identifiants

pubmed: 34702359
doi: 10.1186/s40900-021-00317-7
pii: 10.1186/s40900-021-00317-7
pmc: PMC8547568
doi:

Types de publication

Journal Article

Langues

eng

Pagination

74

Subventions

Organisme : Patient-Centered Outcomes Research Institute
ID : 4466-BMC
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

J Comp Eff Res. 2015 Sep;4(5):515-23
pubmed: 26436953
BMC Health Serv Res. 2014 Feb 26;14:89
pubmed: 24568690
Ann Fam Med. 2017 Mar;15(2):165-170
pubmed: 28289118
J Clin Transl Sci. 2018 Dec;2(6):371-376
pubmed: 31404157
Int J Epidemiol. 2004 Jun;33(3):499-506
pubmed: 15155709
J Am Coll Surg. 2013 Apr;216(4):774-80; discussion 780-1
pubmed: 23415510
Cancer. 2008 Jan 15;112(2):228-42
pubmed: 18008363
Cancer. 2014 Apr 1;120 Suppl 7:1091-6
pubmed: 24643646
Healthc (Amst). 2014 Mar 1;2(1):53-62
pubmed: 24839592
Value Health. 2020 Jun;23(6):677-688
pubmed: 32540224
Transl Behav Med. 2018 Sep 8;8(5):683-691
pubmed: 30202926
Oncologist. 2017 Sep;22(9):1094-1101
pubmed: 28706009
Prog Community Health Partnersh. 2019;13(2):209-217
pubmed: 31178456
Thromb Res. 2017 Feb;150:113-120
pubmed: 27817863
Soc Sci Med. 2010 Oct;71(8):1390-8
pubmed: 20822840
Am J Public Health. 2003 Aug;93(8):1210-3
pubmed: 12893597
Hastings Cent Rep. 1978 Dec;8(6):21-9
pubmed: 721302
J Gen Intern Med. 2019 Feb;34(2):190-191
pubmed: 30218260
Health Promot Pract. 2006 Jul;7(3):312-23
pubmed: 16760238
Cancer Control. 2016 Oct;23(4):327-337
pubmed: 27842322
BMC Health Serv Res. 2017 Oct 23;17(1):693
pubmed: 29058625
Clin Transl Sci. 2012 Aug;5(4):329-32
pubmed: 22883610
Clin Transl Sci. 2014 Jun;7(3):191-5
pubmed: 24841362
Value Health. 2017 Mar;20(3):481-486
pubmed: 28292494
J Comp Eff Res. 2013 May;2(3):313-24
pubmed: 24236630
CA Cancer J Clin. 2019 May;69(3):211-233
pubmed: 30762872
J Am Board Fam Med. 2016 11/12;29(6):775-784
pubmed: 28076261
BMC Med Res Methodol. 2014 Mar 25;14:42
pubmed: 24669751
Am J Public Health. 2010 Apr 1;100 Suppl 1:S30-5
pubmed: 20147679
Am J Public Health. 1997 Nov;87(11):1773-8
pubmed: 9366634
Transl Behav Med. 2020 Dec 31;10(6):1573-1580
pubmed: 31560395
Health Educ Behav. 2011 Aug;38(4):339-47
pubmed: 21460177
J Nurs Adm. 2019 Oct;49(10):473-479
pubmed: 31490796
J Gen Intern Med. 1999 Sep;14(9):537-46
pubmed: 10491242
Cancer. 2020 Jan 1;126(9):1958-1968
pubmed: 32147815

Auteurs

Marjory Charlot (M)

Division of Oncology, University of North Carolina School of Medicine, Houpt Physicians Office Building, 170 Manning Drive, 3rd Floor, Chapel Hill, NC, 27599, USA. mcharlot@med.unc.edu.
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. mcharlot@med.unc.edu.

Kelsi Carolan (K)

University of Connecticut School of Social Work, Hartford, CT, USA.
Boston University School of Social Work, Boston, MA, USA.

Cyrena Gawuga (C)

Macro Department, Boston University School of Social Work, Boston, MA, USA.

Elmer Freeman (E)

Center for Community Health Education Research and Service, Inc., Boston, MA, USA.

Linda Sprague Martinez (L)

Macro Department, Boston University School of Social Work, Boston, MA, USA.

Classifications MeSH